SPR720 / Spero Therap 
Welcome,         Profile    Billing    Logout  
  Diseases    Trials    Trials    News 
3 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
SPR720 / Spero Therap
NCT05496374: A Study to Evaluate the Efficacy, Safety, Tolerability, and Pharmacokinetics of SPR720 as Compared With Placebo for the Treatment of Participants With Mycobacterium Avium Complex (MAC) Pulmonary Disease

Completed
2
25
US
Placebo, SPR720 500 mg, SPR720 1000 mg
Spero Therapeutics
Nontuberculous Mycobacterial Pulmonary Disease (NTM-PD)
10/24
12/24
NCT05966688: A Study to Evaluate the Effect of Co-administration on the Pharmacokinetics of SPR720, Azithromycin, and Ethambutol in Healthy Participants

Completed
1
39
US
SPR720, Azithromycin, Ethambutol
Spero Therapeutics
Healthy Volunteers
01/24
02/24
NCT05955586: A Study to Assess the Intrapulmonary Pharmacokinetics (PK) of SPR719 by Comparing the Plasma, Epithelial Lining Fluid, and Alveolar Macrophage Concentrations Following the Oral Administration of Multiple Doses of SPR720 in Healthy Volunteers.

Completed
1
33
US
SPR720
Spero Therapeutics
Healthy Volunteer
02/24
02/24

Download Options